Skip to main content Back to Top


Propranolol Injection

Products Affected - Description

    • Propranolol intravenous injection, Sandoz, 1 mg/mL, 1 mL vial, 10 count, NDC 00781-3777-95

Reason for the Shortage

    • Ben Venue closed its plant in Bedford, Ohio in July 2014.
    • Fresenius Kabi has propranolol injection available.
    • Sandoz cannot provide a reason for the shortage.
    • West-Ward has propranolol injection available.

Available Products

    • Propranolol intravenous injection, Fresenius Kabi, 1 mg/mL, 1 mL vial, 10 count, NDC 63323-0604-01
    • Propranolol intravenous injection, West-Ward, 1 mg/mL, 1 mL vial, 10 count, NDC 00143-9872-01

Estimated Resupply Dates

    • Sandoz has propranolol 1 mg/mL 1 mL vials temporarily unavailable and the company cannot estimate a new production date.
    • West-Ward and Fresenius Kabi have propranolol injection available.


Updated August 1, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 11, 2014 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins